Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Tetsuro Setoyama"'
Autor:
Koji Minami, Hiroshi Okumura, Kiyokazu Hiwatashi, Sumika Matsukita, Tetsuro Setoyama, Kota Minamimagari, Yusuke Tsuruta, Ichiro Kanetsuki, Yoshito Ogura, Shigeho Maenohara, Shoji Natsugoe
Publikováno v:
Surgical Case Reports, Vol 3, Iss 1, Pp 1-5 (2017)
Abstract Background Malignant mesothelioma commonly arises from the pleura, but can also arise from the peritoneum, pericardium, and tunica vaginalis testis. However, malignant mesothelioma of the liver is extremely rare and coexistence with malignan
Externí odkaz:
https://doaj.org/article/dbf9dc78717f4d46b0ef2d27bda2a02b
Autor:
George A. Calin, Muller Fabbri, Michael J. Keating, Gabriel Lopez-Berestein, Anil K. Sood, Hagop M. Kantarjian, Ignacio I. Wistuba, Massimo Negrini, Ioana Berindan-Neagoe, Ramana V. Davuluri, Tara M. Lichtenberg, William Plunkett, Robert Orlowski, Alessandra Ferrajoli, M. James You, Xuemei Wang, Steliana Calin, Lynne Abruzzo, Dino Amadori, Chad V. Pecot, Vivian R. Ruvolo, Peter P. Ruvolo, Antonino Neri, Fortunato Morabito, Manuela Ferracin, Rajesha Rupaimoole, Vianey Gonzalez-Villasana, Simona Rossi, Milena S. Nicoloso, Xinna Zhang, Lucilla D'Abundo, Roxana S. Redis, Ivan Vannini, Lianchun Xiao, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo, Cristina Ivan, Tetsuro Setoyama, Francesca Fanini, Katrien Van Roosbroeck
Clinical correlation of miR-155 and TP53 expression with survival in the lung adenocarcinoma - TCGA dataset when distinguishing between TP53 wild-type and TP53 mutated samples. (A-B) Kaplan-Meier survival analysis for patients expressing high levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a440f96b8854a0d06c8def7a7d80392c
https://doi.org/10.1158/1078-0432.22463085
https://doi.org/10.1158/1078-0432.22463085
microRNA-10b (miR-10b) expression in pancreatic ductal adenocarcinoma (PDAC), as identified by in situ hybridization, is highly correlated with cancer diagnosis, therapy response, and prognosis. If these findings are further confirmed in prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504269961ffb73b16fc0cadfea083525
https://doi.org/10.1158/1078-0432.c.6520272.v1
https://doi.org/10.1158/1078-0432.c.6520272.v1
Related Article from microRNA-10b: A New Marker or the Marker of Pancreatic Ductal Adenocarcinoma?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2961dfe4b63dbde7f27c40e16c6ac66c
https://doi.org/10.1158/1078-0432.22444713
https://doi.org/10.1158/1078-0432.22444713
Autor:
George A. Calin, Muller Fabbri, Michael J. Keating, Gabriel Lopez-Berestein, Anil K. Sood, Hagop M. Kantarjian, Ignacio I. Wistuba, Massimo Negrini, Ioana Berindan-Neagoe, Ramana V. Davuluri, Tara M. Lichtenberg, William Plunkett, Robert Orlowski, Alessandra Ferrajoli, M. James You, Xuemei Wang, Steliana Calin, Lynne Abruzzo, Dino Amadori, Chad V. Pecot, Vivian R. Ruvolo, Peter P. Ruvolo, Antonino Neri, Fortunato Morabito, Manuela Ferracin, Rajesha Rupaimoole, Vianey Gonzalez-Villasana, Simona Rossi, Milena S. Nicoloso, Xinna Zhang, Lucilla D'Abundo, Roxana S. Redis, Ivan Vannini, Lianchun Xiao, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo, Cristina Ivan, Tetsuro Setoyama, Francesca Fanini, Katrien Van Roosbroeck
Dose-response curves for MEC1 and MEC2 cells treated with fludarabine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::729d3e93129e8324c66a9f8449d875f2
https://doi.org/10.1158/1078-0432.22463100.v1
https://doi.org/10.1158/1078-0432.22463100.v1
Autor:
George A. Calin, Muller Fabbri, Michael J. Keating, Gabriel Lopez-Berestein, Anil K. Sood, Hagop M. Kantarjian, Ignacio I. Wistuba, Massimo Negrini, Ioana Berindan-Neagoe, Ramana V. Davuluri, Tara M. Lichtenberg, William Plunkett, Robert Orlowski, Alessandra Ferrajoli, M. James You, Xuemei Wang, Steliana Calin, Lynne Abruzzo, Dino Amadori, Chad V. Pecot, Vivian R. Ruvolo, Peter P. Ruvolo, Antonino Neri, Fortunato Morabito, Manuela Ferracin, Rajesha Rupaimoole, Vianey Gonzalez-Villasana, Simona Rossi, Milena S. Nicoloso, Xinna Zhang, Lucilla D'Abundo, Roxana S. Redis, Ivan Vannini, Lianchun Xiao, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo, Cristina Ivan, Tetsuro Setoyama, Francesca Fanini, Katrien Van Roosbroeck
Supplementary Table S1 Clinical characteristics of two chronic lymphocytic leukemia patient datasets; Supplementary Table S2 Clinical characteristics of two lung cancer patient datasets; Supplementary Table S3 Clinical characteristics of the ALL data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a261c8be858a08c4414cecdb1b1973
https://doi.org/10.1158/1078-0432.22463082
https://doi.org/10.1158/1078-0432.22463082
Autor:
George A. Calin, Muller Fabbri, Michael J. Keating, Gabriel Lopez-Berestein, Anil K. Sood, Hagop M. Kantarjian, Ignacio I. Wistuba, Massimo Negrini, Ioana Berindan-Neagoe, Ramana V. Davuluri, Tara M. Lichtenberg, William Plunkett, Robert Orlowski, Alessandra Ferrajoli, M. James You, Xuemei Wang, Steliana Calin, Lynne Abruzzo, Dino Amadori, Chad V. Pecot, Vivian R. Ruvolo, Peter P. Ruvolo, Antonino Neri, Fortunato Morabito, Manuela Ferracin, Rajesha Rupaimoole, Vianey Gonzalez-Villasana, Simona Rossi, Milena S. Nicoloso, Xinna Zhang, Lucilla D'Abundo, Roxana S. Redis, Ivan Vannini, Lianchun Xiao, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo, Cristina Ivan, Tetsuro Setoyama, Francesca Fanini, Katrien Van Roosbroeck
Purpose: The oncogenic miR-155 is upregulated in many human cancers, and its expression is increased in more aggressive and therapy-resistant tumors, but the molecular mechanisms underlying miR-155-induced therapy resistance are not fully understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73318acfb8913a0fa3095a7fc1d8d8f0
https://doi.org/10.1158/1078-0432.c.6525306.v1
https://doi.org/10.1158/1078-0432.c.6525306.v1
Autor:
George A. Calin, Muller Fabbri, Michael J. Keating, Gabriel Lopez-Berestein, Anil K. Sood, Hagop M. Kantarjian, Ignacio I. Wistuba, Massimo Negrini, Ioana Berindan-Neagoe, Ramana V. Davuluri, Tara M. Lichtenberg, William Plunkett, Robert Orlowski, Alessandra Ferrajoli, M. James You, Xuemei Wang, Steliana Calin, Lynne Abruzzo, Dino Amadori, Chad V. Pecot, Vivian R. Ruvolo, Peter P. Ruvolo, Antonino Neri, Fortunato Morabito, Manuela Ferracin, Rajesha Rupaimoole, Vianey Gonzalez-Villasana, Simona Rossi, Milena S. Nicoloso, Xinna Zhang, Lucilla D'Abundo, Roxana S. Redis, Ivan Vannini, Lianchun Xiao, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo, Cristina Ivan, Tetsuro Setoyama, Francesca Fanini, Katrien Van Roosbroeck
Clinical correlation of miR-155 expression with survival in leukemia. Kaplan-Meier survival analysis for patients expressing high levels of miR-155 vs. low levels of miR-155 in two CLL cohorts, CLL - NEJM (A) and CLL - Italy (B), and in one ALL cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2720320245acee8d1cd0bf4588bc6048
https://doi.org/10.1158/1078-0432.22463094
https://doi.org/10.1158/1078-0432.22463094
Autor:
George A. Calin, Muller Fabbri, Michael J. Keating, Gabriel Lopez-Berestein, Anil K. Sood, Hagop M. Kantarjian, Ignacio I. Wistuba, Massimo Negrini, Ioana Berindan-Neagoe, Ramana V. Davuluri, Tara M. Lichtenberg, William Plunkett, Robert Orlowski, Alessandra Ferrajoli, M. James You, Xuemei Wang, Steliana Calin, Lynne Abruzzo, Dino Amadori, Chad V. Pecot, Vivian R. Ruvolo, Peter P. Ruvolo, Antonino Neri, Fortunato Morabito, Manuela Ferracin, Rajesha Rupaimoole, Vianey Gonzalez-Villasana, Simona Rossi, Milena S. Nicoloso, Xinna Zhang, Lucilla D'Abundo, Roxana S. Redis, Ivan Vannini, Lianchun Xiao, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo, Cristina Ivan, Tetsuro Setoyama, Francesca Fanini, Katrien Van Roosbroeck
In vivo orthotopic lung cancer model for the role of miR-155 in chemoresistance. (A) Injection and treatment schedule for CDDP (green arrows) and anti-miR negative control (NC) or anti-miR-155 liposomal nanoparticles (red stars) for four different tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3b4c7fe78ec716ff7eaf49dd56d21f
https://doi.org/10.1158/1078-0432.22463097
https://doi.org/10.1158/1078-0432.22463097
Autor:
Alessandra Ferrajoli, Katrien Van Roosbroeck, Massimo Negrini, Ioana Berindan-Neagoe, Dino Amadori, Hagop M. Kantarjian, Peter P. Ruvolo, Manuela Ferracin, Roxana S. Redis, Lianchun Xiao, Xuemei Wang, George A. Calin, Simona Rossi, Ivan Vannini, Antonino Neri, Robert Z. Orlowski, Steliana Calin, Vivian Ruvolo, Fortunato Morabito, Vianey Gonzalez-Villasana, Tara M. Lichtenberg, Gabriel Lopez-Berestein, Lynne V. Abruzzo, Ramana V. Davuluri, Michael J. Keating, Anil K. Sood, Rajesha Rupaimoole, M. James You, William Plunkett, Francesca Fanini, Chad V. Pecot, Tetsuro Setoyama, Xinna Zhang, Ignacio I. Wistuba, Muller Fabbri, Lucilla D’Abundo, Milena S. Nicoloso, Cristina Ivan, Enrique Fuentes-Mattei, Cristian Rodriguez-Aguayo
Publikováno v:
Clinical Cancer Research. 23:2891-2904
Purpose: The oncogenic miR-155 is upregulated in many human cancers, and its expression is increased in more aggressive and therapy-resistant tumors, but the molecular mechanisms underlying miR-155-induced therapy resistance are not fully understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f1fcd64ffc7bde9680d5e1efd09138
https://doi.org/10.1158/1078-0432.ccr-16-1025
https://doi.org/10.1158/1078-0432.ccr-16-1025